Ketamine for Treatment Resistant Depression

Produk Detail:
  • Author : Gustavo H. Vazquez
  • Publisher : Academic Press
  • Pages : 150 pages
  • ISBN : 0128210338
  • Rating : /5 from reviews
CLICK HERE TO GET THIS BOOK >>>Ketamine for Treatment Resistant Depression

Download or Read online Ketamine for Treatment Resistant Depression full in PDF, ePub and kindle. this book written by Gustavo H. Vazquez and published by Academic Press which was released on 15 October 2020 with total page 150 pages. We cannot guarantee that Ketamine for Treatment Resistant Depression book is available in the library, click Get Book button and read full online book in your kindle, tablet, IPAD, PC or mobile whenever and wherever You Like. Ketamine for Treatment-Resistant Depression: Neurobiology and Applications provides a simple, evidence-based overview for neuropsychiatrists and translational researchers on this medication, its mechanisms of actions, eligibility of patients for treatment, and the preparation and implementation of ketamine clinics. Provides efficacy research on ketamine as a treatment for depression Identifies best practices for clinical use, both long-term and acute Discusses the molecular mechanisms and neurobiology of action

Ketamine for Treatment Resistant Depression

Ketamine for Treatment Resistant Depression
  • Author : Gustavo H. Vazquez,Carlos A. Zarate,Elisa Brietzke
  • Publisher : Academic Press
  • Release : 15 October 2020
GET THIS BOOK Ketamine for Treatment Resistant Depression

Ketamine for Treatment-Resistant Depression: Neurobiology and Applications provides a simple, evidence-based overview for neuropsychiatrists and translational researchers on this medication, its mechanisms of actions, eligibility of patients for treatment, and the preparation and implementation of ketamine clinics. Provides efficacy research on ketamine as a treatment for depression Identifies best practices for clinical use, both long-term and acute Discusses the molecular mechanisms and neurobiology of action

Ketamine for Treatment Resistant Depression

Ketamine for Treatment Resistant Depression
  • Author : Sanjay J. Mathew,Carlos A. Zarate, Jr.
  • Publisher : Adis
  • Release : 05 October 2016
GET THIS BOOK Ketamine for Treatment Resistant Depression

This book brings together an international group of clinicians and researchers from a broad swath of inter-related disciplines to offer the most up-to-date information about clinical and preclinical research into ketamine and second-generation “ketamine-like” fast-acting antidepressants. Currently available antidepressant medications act through monoaminergic systems, are ineffective for many individuals suffering from depression, and are associated with a delayed onset of peak efficacy of several months. The unexpected emergence of ketamine, an anesthetic N-methyl-D-aspartate (NMDA) receptor antagonist, as a rapid-acting antidepressant

Ketamine for Depression

Ketamine for Depression
  • Author : Dr. Stephen J. Hyde
  • Publisher : Xlibris Corporation
  • Release : 04 September 2015
GET THIS BOOK Ketamine for Depression

Given the unacceptably high rates of suffering, disability and premature death experienced by people with treatment-resistant depression and the surprisingly low rates of problems arising from the use of ketamine to treat the disorder, this is a therapy that all patients and their doctors should be discussing. This book summarises the research that has been carried out into ketamine for the treatment of depression over the past 15 years and, most importantly, describes different ways of using ketamine that are both

11 THE USE OF SUBCUTANEOUS KETAMINE FOR TREATMENT RESISTANT DEPRESSION

11   THE USE OF SUBCUTANEOUS KETAMINE FOR TREATMENT RESISTANT DEPRESSION
  • Author : Mariane Quieroti Rodrigues
  • Publisher : Unknown
  • Release : 16 June 2021
GET THIS BOOK 11 THE USE OF SUBCUTANEOUS KETAMINE FOR TREATMENT RESISTANT DEPRESSION

Introduction: Major depressive disorder is highly common with up to 50% to 60% of the patients not achieving adequate response following antidepressant treatment. In this scenario, ketamine emerges as an important alternative to conventional treatments, with its action of being an antagonist of N-methyl- D-aspartate (NMDA) receptor, once its has a quick and effective action. Ketamine is most frequently administered intravenous. However, oral, sublingual, transmucosal, intranasal, subcutaneous (SC), and intramuscular routes of administration have also been examined.Aim: This study aims to

Ketamine for Treatment Resistant Depression

Ketamine for Treatment Resistant Depression
  • Author : Gustavo H. Vazquez,Carlos A. Zarate,Elisa Brietzke
  • Publisher : Academic Press
  • Release : 01 October 2020
GET THIS BOOK Ketamine for Treatment Resistant Depression

Ketamine for Treatment-Resistant Depression: Neurobiology and Applications provides a simple, evidence-based overview for neuropsychiatrists and translational researchers on this medication, its mechanisms of actions, eligibility of patients for treatment, and the preparation and implementation of ketamine clinics. Provides efficacy research on ketamine as a treatment for depression Identifies best practices for clinical use, both long-term and acute Discusses the molecular mechanisms and neurobiology of action

Ketamine for Treatment Resistant Depression

Ketamine for Treatment Resistant Depression
  • Author : Sanjay J. Mathew,Carlos A. Zarate, Jr.
  • Publisher : Adis
  • Release : 07 July 2018
GET THIS BOOK Ketamine for Treatment Resistant Depression

This book brings together an international group of clinicians and researchers from a broad swath of inter-related disciplines to offer the most up-to-date information about clinical and preclinical research into ketamine and second-generation “ketamine-like” fast-acting antidepressants. Currently available antidepressant medications act through monoaminergic systems, are ineffective for many individuals suffering from depression, and are associated with a delayed onset of peak efficacy of several months. The unexpected emergence of ketamine, an anesthetic N-methyl-D-aspartate (NMDA) receptor antagonist, as a rapid-acting antidepressant

Ketamine

Ketamine
  • Author : Kenji Hashimoto,Soichiro Ide,Kazutaka Ikeda
  • Publisher : Springer Nature
  • Release : 05 March 2020
GET THIS BOOK Ketamine

This book presents the latest data from basic research and clinical trials supporting the effectiveness of ketamine as a treatment for depression, bipolar disorder, and suicidal behavior, setting these positive findings within the context of the serious problem of ketamine abuse. The first part of the book focuses on the evidence regarding ketamine abuse, with specific reference to Asian countries, and discusses countermeasures and complication management. It then addresses the mechanisms underlying the antidepressant and side effects of ketamine, which

05 KETAMINE ANTIDEPRESSANT ACTIONS IN ELECTROCONVULSIVE THERAPY OF TREATMENT RESISTANT DEPRESSION

05   KETAMINE ANTIDEPRESSANT ACTIONS IN ELECTROCONVULSIVE THERAPY OF TREATMENT RESISTANT DEPRESSION
  • Author : Bruno Josu00e9 Prates
  • Publisher : Unknown
  • Release : 16 June 2021
GET THIS BOOK 05 KETAMINE ANTIDEPRESSANT ACTIONS IN ELECTROCONVULSIVE THERAPY OF TREATMENT RESISTANT DEPRESSION

Background and aims: Major depressive disorder affects approximately 5% of the population with nearly 1-third of patients failing to achieve remission, despite adequate pharmacological treatment [1]. Although electroconvulsive therapy (ECT) is the gold standard approach for treatment resistant depression (TRD), a considerable fraction of patients also show a delayed improvement or appear to be resistant to ECT. One of the most promising rapid-acting antidepressants is ketamine, a noncompetitive N-methyl-D-Aspartate receptor antagonist that can be used as an anesthetic during ECT to augment

Ready Set Action Potential Breakthrough Therapy for Treatment Resistant Depression

Ready  Set  Action  Potential Breakthrough Therapy for Treatment Resistant Depression
  • Author : Alvin Garlejo
  • Publisher : Unknown
  • Release : 16 June 2021
GET THIS BOOK Ready Set Action Potential Breakthrough Therapy for Treatment Resistant Depression

Major depressive disorder is a psychiatric illness that is associated with a variety of debilitating symptoms such as persistent sadness, lack of interest and motivation, lassitude, pessimistic thoughts, and in severe cases, suicidal ideation and behavior. Current psychological and pharmacological treatments have been demonstrated efficacious; however, an ever-growing number of individuals frequently report minimal to no improvement with these treatments; and in some cases, a worsening of symptoms. This inadequacy to treatment is commonly known as treatment-resistant depression. At Kadima

Ketamine for Treatment Resistant Depression

Ketamine for Treatment Resistant Depression
  • Author : Sanjay J. Mathew,Carlos A. Zarate, Jr.
  • Publisher : Springer
  • Release : 25 November 2016
GET THIS BOOK Ketamine for Treatment Resistant Depression

This book brings together an international group of clinicians and researchers from a broad swath of inter-related disciplines to offer the most up-to-date information about clinical and preclinical research into ketamine and second-generation “ketamine-like” fast-acting antidepressants. Currently available antidepressant medications act through monoaminergic systems, are ineffective for many individuals suffering from depression, and are associated with a delayed onset of peak efficacy of several months. The unexpected emergence of ketamine, an anesthetic N-methyl-D-aspartate (NMDA) receptor antagonist, as a rapid-acting antidepressant

Ketamine

Ketamine
  • Author : Kenji Hashimoto,Soichiro Ide,Kazutaka Ikeda
  • Publisher : Springer
  • Release : 06 March 2021
GET THIS BOOK Ketamine

This book presents the latest data from basic research and clinical trials supporting the effectiveness of ketamine as a treatment for depression, bipolar disorder, and suicidal behavior, setting these positive findings within the context of the serious problem of ketamine abuse. The first part of the book focuses on the evidence regarding ketamine abuse, with specific reference to Asian countries, and discusses countermeasures and complication management. It then addresses the mechanisms underlying the antidepressant and side effects of ketamine, which

Ketamine

Ketamine
  • Author : Kenji Hashimoto,Soichiro Ide,Kazutaka Ikeda
  • Publisher : Springer
  • Release : 28 April 2020
GET THIS BOOK Ketamine

This book presents the latest data from basic research and clinical trials supporting the effectiveness of ketamine as a treatment for depression, bipolar disorder, and suicidal behavior, setting these positive findings within the context of the serious problem of ketamine abuse. The first part of the book focuses on the evidence regarding ketamine abuse, with specific reference to Asian countries, and discusses countermeasures and complication management. It then addresses the mechanisms underlying the antidepressant and side effects of ketamine, which

Intravenous Ketamine for Treatment of Major Depressive Disorder in a Patient with a History of Repetitive Traumatic Brain Injuries

Intravenous Ketamine for Treatment of Major Depressive Disorder in a Patient with a History of Repetitive Traumatic Brain Injuries
  • Author : John William III
  • Publisher : Unknown
  • Release : 16 June 2021
GET THIS BOOK Intravenous Ketamine for Treatment of Major Depressive Disorder in a Patient with a History of Repetitive Traumatic Brain Injuries

INTRODUCTION: Depression is the most common psychiatric disorder that occurs following a Traumatic Brain Injury. To date, there are limited studies demonstrating the effectiveness of current treatments for this disorder and even less for those with repetitive injuries or rTBIs. Ketamine has been demonstrated to be effective in successfully treating depression and helping with damaged connectivity within the brain. It can be hypothesized that Ketamine may help with both of these areas that many TBI patients face after injury. This